纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2024-12-31 Ocular Therapeutix Inc 0.13%
2024-12-31 Nurix Therapeutics Inc 0.13%
2024-12-31 诺瓦瓦克斯医药 0.13%
2024-12-31 Arvinas Holding Co LLC 0.13%
2024-12-31 ANI Pharmaceuticals Inc 0.12%
2024-12-31 Harrow Health Inc 0.12%
2024-12-31 Intellia Therapeutics Inc 0.12%
2024-12-31 Immunocore Holdings plc ADR 0.12%
2024-12-31 Ardelyx Inc 0.12%
2024-12-31 Rocket Pharmaceuticals Inc 0.11%
2024-12-31 Enliven Therapeutics Inc 0.11%
2024-12-31 Innoviva Inc 0.11%
2024-12-31 Syndax Pharmaceuticals Inc 0.11%
2024-12-31 ARS Pharmaceuticals Inc 0.1%
2024-12-31 Zymeworks Inc 0.1%
2024-12-31 Avadel Pharmaceuticals plc 0.1%
2024-12-31 Vir Biotechnology Inc 0.1%
2024-12-31 89bio Inc 0.09%
2024-12-31 Collegium Pharmaceutical Inc 0.09%
2024-12-31 Cogent Biosciences Inc 0.09%

投资模拟

公告&资料